Physician
J & I Pediatric Care Center
J & I Pediatric Care Center was paid $8.64M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoJ & I PEDIATRIC CARE CENTER
DEARBORN, MI 48120
DEARBORN, MI 48120
33aNPI1932229382assigned 03/30/2007
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$8.64M
24GClaims292,620
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Michigan
Rank by total paid#1 of 46
Median peer was paid$567K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,900 | $1.22M | |
| 2019 | 46,791 | $1.24M | |
| 2020 | 33,828 | $863K | |
| 2021 | 35,563 | $1.08M | |
| 2022 | 41,411 | $1.35M | |
| 2023 | 43,487 | $1.46M | |
| 2024incomplete | 45,640 | $1.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 48,182 | 43,563 | $3.20M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.2% | 20,097 | 18,665 | $797K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.9% | 9,871 | 9,825 | $768K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.8% | 9,537 | 9,498 | $762K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.7% | 7,770 | 7,726 | $666K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.5% | 7,822 | 7,305 | $562K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.5% | 14,308 | 14,192 | $301K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.2% | 27,032 | 26,655 | $281K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 2,135 | 2,105 | $232K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.5% | 16,110 | 15,428 | $218K |
| 99381 | 1.7% | 1,684 | 1,673 | $151K | |
| 99442 | 1.7% | 1,859 | 1,809 | $148K |
55 more codes
| 92587 | 1.2% | 8,067 | $101K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 6,890 | $98K |
| 17110 | 1.0% | 1,324 | $89K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,455 | $49K |
| 85018 | <1% | 18,002 | $38K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,134 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,548 | $29K |
| 90474 | <1% | 3,819 | $26K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,185 | $19K |
| 96127 | <1% | 3,420 | $19K | |
| 99177 | <1% | 6,769 | $13K | |
| 99383 | <1% | 136 | $13K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 866 | $8K |
| 87807 | <1% | 462 | $5K | |
| 99384 | <1% | 41 | $4K | |
| 86328 | <1% | 93 | $3K | |
| 96160 | <1% | 1,570 | $3K | |
| 99382 | <1% | 24 | $2K | |
| 81003 | <1% | 1,143 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 25 | $2K |
| 90621 | <1% | 1,916 | $1K | |
| 99441 | <1% | 24 | $1K | |
| 90671 | <1% | 1,166 | $999.80 | |
| 90651 | <1% | 3,570 | $972.42 | |
| 99401 | <1% | 73 | $622.30 | |
| 90619 | <1% | 1,553 | $172.52 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14 | $158.57 |
| 90716 | <1% | 3,765 | $149.89 | |
| 90688 | <1% | 7,265 | $133.02 | |
| 99000 | <1% | 191 | $89.25 | |
| 86580 | <1% | 14 | $67.52 | |
| 81002 | <1% | 56 | $63.14 | |
| 90685 | <1% | 606 | $43.62 | |
| 90715 | <1% | 2,083 | $30.95 | |
| 90686 | <1% | 1,960 | $19.03 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 54 | $10.35 |
| 90633 | 0% | 3,953 | $0.00 | |
| 90670 | 0% | 4,911 | $0.00 | |
| 90648 | 0% | 1,491 | $0.00 | |
| 90734 | 0% | 1,915 | $0.00 | |
| 83655 | 0% | 287 | $0.00 | |
| 90713 | 0% | 2,529 | $0.00 | |
| 90687 | 0% | 342 | $0.00 | |
| 90707 | 0% | 3,705 | $0.00 | |
| 90700 | 0% | 3,588 | $0.00 | |
| 90714 | 0% | 27 | $0.00 | |
| 90658 | 0% | 204 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 71 | $0.00 |
| 90697 | 0% | 1,594 | $0.00 | |
| 90680 | 0% | 3,896 | $0.00 | |
| 90744 | 0% | 2,263 | $0.00 | |
| 90698 | 0% | 2,764 | $0.00 | |
| 90656 | 0% | 357 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 20 | $0.00 |
| 94760 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHADDAD, MANAL (OFFICE MANAGER)